IGF-1 LR3 Dosage: Doses Studied, Units and Chart
What doses of IGF-1 LR3 have been used in published research, how they convert to syringe units, and what is still unknown.
- Doses studied
- 8 studies
- with a stated dose, listed below
- Frequency
- Varies by study
- as used in studies
- Half-life
- 563 min half-life in wound fluid (versus 872 min for IGF-I)
- wound chamber (rat), rat · The American journal of physiology 1999, PMID 10198302
- Vial sizes sold
- 0.1 mg, 1 mg
Doses used in published studies
Each dose below is quoted from a study abstract, strongest design first. Animal doses are labelled and do not translate directly to people. None of them is a recommendation.
| Dose | Frequency and route | Study type | Source |
|---|---|---|---|
| 1.17 ± 0.12 μg·kg-1·h-1 | continuous · fetal infusion · 1 wk | Animal · sheep (not a human result)n = 14 | American journal of physiology. Endocrinology and metabolism 2025, PMID 39679943 |
| not stated | not stated · intranasal · 7 months | Animal · mouse (not a human result) | Journal of Alzheimer's disease 2025, PMID 39610283 |
| 2, 4 or 8 microg/h (Expt 1); 8 then 16 microg/h (Expt 2) | continuous · infusion · 8 d (Expt 1); 18 d (Expt 2) | Animal · pig (not a human result) | The British journal of nutrition 2002, PMID 12067429 |
| 180 micrograms/kg/day | continuous · infusion · 4 days | Animal · pig (not a human result) | The Journal of endocrinology 1997, PMID 9488001 |
| 120 micrograms/day LR3IGF-I | continuous · continuous infusion · 7 days | Animal · guinea pig (not a human result) | The Journal of endocrinology 1995, PMID 7561636 |
| 2.5 mg/kg/day | continuous · infusion · 3 days | Animal · rat (not a human result) | Gut 1995, PMID 8549937 |
| 200 or 500 microgram/day | continuous · infusion by osmotic minipump · 6-7 days | Animal · rat (not a human result) | The Biochemical journal 1994, PMID 8053901 |
| Graded doses up to 695 micrograms/day (IGF-I) | continuous · infusion by mini-osmotic pump · 7 days | Animal · rat (not a human result) | The Biochemical journal 1993, PMID 7683875 |
Dose to syringe units
For a 1 mg vial mixed with 2 mL of bacteriostatic water (0.5 mg/mL), on a U-100 syringe. These are reference amounts for the math, not suggested doses.
- 10 mcg
- 2 u
- 20 mcg
- 4 u
- 50 mcg
- 10 u
- 100 mcg
- 20 u
Before anyone considers it
- IGF-1 LR3 is Not FDA approved · research chemical; research-chemical versions are not the approved drug.
- Compounded and research-chemical versions are not the approved product and are not checked by the FDA for identity, purity or dose.
- Reconstitution math (mg vs mcg, units vs mL) is the most asked question in peptide forums. Check every number twice.
- People who are pregnant, breastfeeding, or have a chronic condition need medical advice first.
Common questions
How many units is 50 mcg of IGF-1 LR3?
It depends on the water added. A 1 mg vial with 2 mL of water gives 0.5 mg/mL, so 50 mcg is 10 units on a U-100 syringe. Use the calculator for other mixes.
Is IGF-1 LR3 FDA approved?
IGF-1 LR3 is Not FDA approved · research chemical. Products sold as research chemicals are not the approved drug and are not checked by the FDA.
More on IGF-1 LR3
Sources
- 1Metric (SI) Prefixes (NIST Reference on Constants, Units, and Uncertainty)National Institute of Standards and Technology (NIST) · 2025physics.nist.govAccessed 2 Oct 2026
- 2BASAGLAR (insulin glargine) injection, prescribing information (DailyMed)U.S. Food and Drug Administration / DailyMed (Eli Lilly and Company label) · 2026dailymed.nlm.nih.govAccessed 2 Oct 2026
- 3IGF-1 LR3 does not promote growth in late-gestation growth-restricted fetal sheep.American journal of physiology. Endocrinology and metabolism · 2025PMID 39679943Accessed 2 Oct 2026
- 4Intranasal long R3 insulin-like growth factor-1 treatment promotes amyloid plaque remodeling in cerebral cortex but fails to preserve cognitive function in male 5XFAD mice.Journal of Alzheimer's disease : JAD · 2025PMID 39610283Accessed 2 Oct 2026
- 5Insulin-like growth factor-I and analogues increase growth in artificially-reared neonatal pigs.The British journal of nutrition · 2002PMID 12067429Accessed 2 Oct 2026
- 6Long [R3] insulin-like growth factor-I reduces growth, plasma growth hormone, IGF binding protein-3 and endogenous IGF-I concentrations in pigs.The Journal of endocrinology · 1997PMID 9488001Accessed 2 Oct 2026
- 7Long R3 insulin-like growth factor-I (IGF-I) infusion stimulates organ growth but reduces plasma IGF-I, IGF-II and IGF binding protein concentrations in the guinea pig.The Journal of endocrinology · 1995PMID 7561636Accessed 2 Oct 2026
- 8Administration of insulin-like growth factor-I (IGF-I) peptides for three days stimulates proliferation of the small intestinal epithelium in rats.Gut · 1995PMID 8549937Accessed 2 Oct 2026
- 9Effects of insulin and insulin-like growth factors on protein and energy metabolism in tumour-bearing rats.The Biochemical journal · 1994PMID 8053901Accessed 2 Oct 2026
- 10Insulin-like growth factor-I and more potent variants restore growth of diabetic rats without inducing all characteristic insulin effects.The Biochemical journal · 1993PMID 7683875Accessed 2 Oct 2026
- 11Clearance of IGFs and insulin from wounds: effect of IGF-binding protein interactions.The American journal of physiology · 1999PMID 10198302Accessed 2 Oct 2026
Found an error? Report a correction.